Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men-Reference-Cited by-同舟云学术

Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men

Published:2018-06 Issue:6 Volume:73 Page:941-948
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sjoberg Daniel D.,Vickers Andrew J.,Assel Melissa,Dahlin Anders,Poon Bing Ying,Ulmert David,Lilja Hans

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schroder;Lancet,2014

2. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study;Vickers;BMJ,2010

3. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study;Vickers;BMJ,2013

4. Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer;Preston;J Clin Oncol,2016

5. An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection;Vickers;J Natl Cancer Inst,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial;European Urology;2024-09

2. Nanomedicine for Prostate Cancer Treatment;BioNanoScience;2024-05-28

3. The Clinical Impact of the 4Kscore Test on Prostate Biopsy Decision Making in the Setting of MRI;JU Open Plus;2024-04

4. Prostate cancer: Novel genetic and immunologic biomarkers;Clinica Chimica Acta;2024-03

5. Clinical Biofluid Assays for Prostate Cancer;Cancers;2023-12-28